Cor Vasa 2012, 54(7-8):e248-e252 | DOI: 10.1016/j.crvasa.2012.08.004

Arterial hypertension and atrial fibrillation: selecting antihypertensive therapy

Jiří Widimský jr.
Centrum pro hypertenzi, III. interní klinika, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha, Česká republika

Keywords: Antihypertenzní léčba; Fibrilace síní; Hypertenze

Received: August 10, 2012; Accepted: August 15, 2012; Published: July 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský J. Arterial hypertension and atrial fibrillation: selecting antihypertensive therapy. Cor Vasa. 2012;54(7-8):e248-252. doi: 10.1016/j.crvasa.2012.08.004.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. G. Mancia, G. De Backer, A. Dominiczak, et al., 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Journal of Hypertension 25 (2007) 1105-1187. Go to original source... Go to PubMed...
    2. G. Mancia, S. Laurent, E. Agabiti-Rosei, et al., Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document, Journal of Hypertension 27 (11) (2009) 2121-2158. Go to original source... Go to PubMed...
    3. J. Widimský jr, R. Cífková, J. Špinar, et al., Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007. Doporučení České společnosti pro hypertenzi, Cor et Vasa 50 (1) (2008) K5-K22.
    4. A.J. Manolis, E.A. Rosei, A. Coca, et al., Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension, Journal of Hypertension 30 (2012) 239-252. Go to original source... Go to PubMed...
    5. J.S. Healey, A. Baranchuk, E. Crystal, et al., Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a metaanalysis, Journal of the American College of Cardiology 45 (2005) 1832-1839. Go to original source... Go to PubMed...
    6. J.S. Kalus, C.I. Coleman, C.M. White, The impact of suppressing the renin-angiotensin system on atrial fibrillation, Journal of Clinical Pharmacology 46 (2006) 21-28. Go to original source... Go to PubMed...
    7. M.P. Schneider, T.A. Hua, M. Böhm, et al., Prevention of atrial fibrillation by renin-angiotensin system-inhibition a meta-analysis, Journal of the American College of Cardiology 55 (2010) 2299-2307. Go to original source... Go to PubMed...
    8. R.E. Schmieder, S.E. Kjeldsen, S. Julius, et al., VALUE Trial Group, Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. Journal of Hypertension 26 (2008) 403-411. Go to original source... Go to PubMed...
    9. E. Gerdts, K. Wachtell, P. Omvik, et al., Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial, Hypertension 49 (2007) 311-316. Go to original source... Go to PubMed...
    10. ONTARGET Investigators, S. Yusuf, K.K. Teo, J. Pogue, et al., Telmisartan, ramipril, or both in patients at high risk for vascular events, The New England Journal of Medicine 358 (2008) 1547-1559. Go to original source... Go to PubMed...
    11. Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (TRANSCEND) Investigators, S. Yusuf, K. Teo, C. Anderson, et al., Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial, Lancet 372 (2008) 1174-1183.
    12. S. Yusuf, H.C. Diener, R.L. Sacco, et al., PROFESS Study Group, Telmisartan to prevent recurrent stroke and cardiovascular events, The New England Journal of Medicine 359 (2008) 1225-1237. Go to original source... Go to PubMed...
    13. A. Tveit, I. Seljeflot, I. Grundvold, et al., Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation, American Journal of Cardiology 99 (2007) 1544-1548. Go to original source... Go to PubMed...
    14. Investigators GISSI-AF, M. Disertori, R. Latini, S. Barlera, et al., Valsartan for prevention of recurrent atrial fibrillation, The New England Journal of Medicine 360 (2009) 1606-1617. Go to original source... Go to PubMed...
    15. O.D. Pedersen, H. Bagger, L. Kober, C. Torp-Pedersen, Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction, Circulation 100 (4) (1999) 376-380. Go to original source... Go to PubMed...
    16. P.M. Okin, K. Wachtell, R.B. Devereux, et al., Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension, the Journal of the American Medical Association 296 (2006) 1242-1248. Go to original source... Go to PubMed...
    17. I.A. Nasr, A. Bouzamondo, J.S. Hulot, et al., Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis, European Heart Journal 28 (2007) 457-462. Go to original source... Go to PubMed...
    18. B.A. Schaer, C. Schneider, S.S. Jick, et al., Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study, Annals of Internal Medicine 152 (2010) 78-84. Go to original source... Go to PubMed...
    19. A. De Simone, G. Stabile, D.F. Vitale, et al., Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion, Journal of the American College of Cardiology 34 (1999) 810-814. Go to original source... Go to PubMed...
    20. T. Van Noord, I.C. Van Gelder, R.G. Tieleman, et al., VERDICT: the Verapamil versus Digoxin Cardioversion Trial: a randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation, Journal of Cardiovascular Electrophysiology 12 (2001) 766-769. Go to original source... Go to PubMed...
    21. S. Niwano, H. Fukaya, T. Sasaki, et al., Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring, Europace 9 (12) (2007) 1209-1215. Go to original source... Go to PubMed...
    22. J.D. Lefrandt, J. Heitmann, K. Sevre, et al., The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study, American Journal of Hypertension 14 (11 Pt 1) (2001) 1083-1089. Go to original source... Go to PubMed...
    23. P.L. L'Allier, A. Ducharme, P.F. Keller, et al., Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation, Journal of the American College of Cardiology 44 (2004) 159-164. Go to original source... Go to PubMed...
    24. P. Milliez, X. Girerd, P.F. Plouin, et al., Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism, Journal of the American College of Cardiology 45 (2005) 1243-1248. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes